ZTS vs. BMY, PFE, GSK, TAK, REGN, VRTX, GMAB, ALNY, BMRN, and SNY
Should you be buying Zoetis stock or one of its competitors? The main competitors of Zoetis include Bristol-Myers Squibb (BMY), Pfizer (PFE), GSK (GSK), Takeda Pharmaceutical (TAK), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Genmab A/S (GMAB), Alnylam Pharmaceuticals (ALNY), BioMarin Pharmaceutical (BMRN), and Sanofi (SNY). These companies are all part of the "pharmaceutical preparations" industry.
Bristol-Myers Squibb (NYSE:BMY) and Zoetis (NYSE:ZTS) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, media sentiment, institutional ownership, community ranking and risk.
Zoetis has a net margin of 27.43% compared to Zoetis' net margin of -13.50%. Bristol-Myers Squibb's return on equity of 51.25% beat Zoetis' return on equity.
Bristol-Myers Squibb received 183 more outperform votes than Zoetis when rated by MarketBeat users. However, 77.76% of users gave Zoetis an outperform vote while only 66.87% of users gave Bristol-Myers Squibb an outperform vote.
76.4% of Bristol-Myers Squibb shares are owned by institutional investors. Comparatively, 92.8% of Zoetis shares are owned by institutional investors. 0.1% of Bristol-Myers Squibb shares are owned by company insiders. Comparatively, 0.1% of Zoetis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Bristol-Myers Squibb has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. Comparatively, Zoetis has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500.
Bristol-Myers Squibb currently has a consensus price target of $60.00, indicating a potential upside of 33.78%. Zoetis has a consensus price target of $218.00, indicating a potential upside of 37.61%. Given Bristol-Myers Squibb's stronger consensus rating and higher probable upside, analysts clearly believe Zoetis is more favorable than Bristol-Myers Squibb.
Bristol-Myers Squibb has higher revenue and earnings than Zoetis. Bristol-Myers Squibb is trading at a lower price-to-earnings ratio than Zoetis, indicating that it is currently the more affordable of the two stocks.
Bristol-Myers Squibb pays an annual dividend of $2.40 per share and has a dividend yield of 5.4%. Zoetis pays an annual dividend of $1.73 per share and has a dividend yield of 1.1%. Bristol-Myers Squibb pays out -77.4% of its earnings in the form of a dividend. Zoetis pays out 34.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Zoetis has increased its dividend for 12 consecutive years. Bristol-Myers Squibb is clearly the better dividend stock, given its higher yield and lower payout ratio.
In the previous week, Bristol-Myers Squibb had 54 more articles in the media than Zoetis. MarketBeat recorded 80 mentions for Bristol-Myers Squibb and 26 mentions for Zoetis. Bristol-Myers Squibb's average media sentiment score of 0.58 beat Zoetis' score of 0.11 indicating that Zoetis is being referred to more favorably in the news media.
Summary
Zoetis beats Bristol-Myers Squibb on 15 of the 21 factors compared between the two stocks.
Get Zoetis News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZTS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ZTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
